| Autor: |
Low-Calle AM; Department of Biological Sciences, Columbia University, New York, New York, USA., Ghoneima H; Department of Biological Sciences, Columbia University, New York, New York, USA., Ortega N; Department of Biological Sciences, Columbia University, New York, New York, USA., Cuibus AM; Department of Biological Sciences, Columbia University, New York, New York, USA., Katz C; Department of Biological Sciences, Columbia University, New York, New York, USA., Prives C; Department of Biological Sciences, Columbia University, New York, New York, USA., Prywes R; Department of Biological Sciences, Columbia University, New York, New York, USA. |
| Abstrakt: |
The p63 transcription factor, a member of the p53 family, plays an oncogenic role in squamous cell carcinomas, while in breast cancers its expression is often repressed. In the canonical conserved Hippo pathway, known to play a complex role in regulating growth of cancer cells, protein kinases MST1/2 and LATS1/2 act sequentially to phosphorylate and inhibit the YAP/TAZ transcription factors. We found that in MCF10A mammary epithelial cells as well as in squamous and breast cancer cell lines, expression of ΔNp63 RNA and protein is strongly repressed by inhibition of the Hippo pathway protein kinases. While MST1/2 and LATS1 are required for p63 expression, the next step of the pathway, namely phosphorylation and degradation of the YAP/TAZ transcriptional activators is not required for p63 repression. This suggests that regulation of p63 expression occurs by a noncanonical version of the Hippo pathway. We identified similarly regulated genes, suggesting the broader importance of this pathway. Interestingly, lowering p63 expression lead to increased YAP protein levels, indicating crosstalk of the YAP/TAZ-independent and -dependent branches of the Hippo pathway. These results, which reveal the intersection of the Hippo and p63 pathways, may prove useful for the control of their activities in cancer cells. |
